Ipsen S.A. (EPA:IPN)
France · Delayed Price · Currency is EUR 156.60
+0.80 (0.51%)
May 29, 2026, 5:35 PM CET
Ipsen Employees
Ipsen had 5,535 employees as of December 31, 2025. The number of employees increased by 177 or 3.30% compared to the previous year.
Employees
5,535
Change (1Y)
177
Growth (1Y)
3.30%
Revenue / Employee
€709,883
Profits / Employee
€80,126
Market Cap
12.86B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 5,535 | 177 | 3.30% | 5,535 | 0 |
| Dec 31, 2024 | 5,358 | 33 | 0.62% | 5,358 | 0 |
| Dec 31, 2023 | 5,325 | 253 | 4.99% | 5,325 | 0 |
| Dec 31, 2022 | 5,072 | -672 | -11.70% | 5,072 | 0 |
| Dec 31, 2021 | 5,744 | 41 | 0.72% | 5,744 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| EssilorLuxottica Société anonyme | 155,975 |
| emeis Société anonyme | 84,586 |
| Sanofi | 74,846 |
| Clariane SE | 70,685 |
| Eurofins Scientific SE | 65,694 |
| Ramsay Générale de Santé | 40,494 |
| bioMérieux | 15,226 |
| Sartorius Stedim Biotech | 10,456 |
Ipsen News
- 18 days ago - Ipsen S.A. – Evolution of the composition of the Board of Directors - GlobeNewsWire
- 18 days ago - Annual General Meeting of Ipsen S.A. held on 13 May 2026 - GlobeNewsWire
- 5 weeks ago - Ipsen Earnings Call Transcript: Q1 2026 - Transcripts
- 5 weeks ago - Ipsen Earnings release: Q1 2026 - Filings
- 5 weeks ago - Ipsen Slides: Q1 2026 - Filings
- 3 months ago - Ipsen S.A. publishes its 2025 Consolidated Financial Statements - GlobeNewsWire
- 3 months ago - Ipsen Earnings Call Transcript: H2 2025 - Transcripts
- 3 months ago - Ipsen Annual report: H2 2025 - Filings